The Pennant Group, Inc. - Common Stock (PNTG)
26.67
+0.76 (2.93%)
NASDAQ · Last Trade: Nov 21st, 11:24 PM EST
Detailed Quote
| Previous Close | 25.91 |
|---|---|
| Open | 25.83 |
| Bid | 26.65 |
| Ask | 26.67 |
| Day's Range | 25.57 - 26.95 |
| 52 Week Range | 21.18 - 32.00 |
| Volume | 271,095 |
| Market Cap | 756.41M |
| PE Ratio (TTM) | 35.56 |
| EPS (TTM) | 0.8 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 309,613 |
Chart
About The Pennant Group, Inc. - Common Stock (PNTG)
The Pennant Group Inc is a healthcare services company that specializes in providing high-quality, home healthcare and senior living services across the United States. The company operates through a network of subsidiaries that deliver personalized care to patients in their homes and within various community settings, focusing on enhancing the quality of life and independence of seniors and individuals with complex health needs. By integrating innovative care models and fostering partnerships with healthcare providers, Pennant aims to create a supportive environment that promotes wellness and improves overall patient outcomes. Read More
News & Press Releases
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
Via StockStory · November 21, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how senior health, home health & hospice stocks fared in Q3, starting with Chemed (NYSE:CHE).
Via StockStory · November 20, 2025
Over the past six months, The Pennant Group’s shares (currently trading at $26.51) have posted a disappointing 9.9% loss, well below the S&P 500’s 11.3% gain. This may have investors wondering how to approach the situation.
Via StockStory · November 19, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how senior health, home health & hospice stocks fared in Q3, starting with The Pennant Group (NASDAQ:PNTG).
Via StockStory · November 19, 2025
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Via StockStory · November 17, 2025
Shares of senior living provider The Pennant Group (NASDAQ:PNTG)
jumped 1.4% in the morning session after RBC Capital raised its price target on the company to $39 from $34 and maintained its "Outperform" rating.
Via StockStory · November 17, 2025
The Pennant Group’s third quarter results were met with a negative market reaction despite revenue and adjusted EPS both surpassing Wall Street expectations. Management pointed to strong operational execution in home health, hospice, and senior living as key drivers, with CEO Brent Guerisoli highlighting that “new highs in revenue, census, occupancy and earnings” were achieved. However, investors weighed concerns about operating margin compression and the complexity of integrating a large acquisition, as the company prepares for further growth amid evolving industry dynamics.
Via StockStory · November 12, 2025
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.
Via StockStory · November 11, 2025
Senior living provider The Pennant Group (NASDAQ:PNTG) announced better-than-expected revenue in Q3 CY2025, with sales up 26.8% year on year to $229 million. The company’s full-year revenue guidance of $930 million at the midpoint came in 3.5% above analysts’ estimates. Its non-GAAP profit of $0.30 per share was 4.6% above analysts’ consensus estimates.
Via StockStory · November 7, 2025
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · November 6, 2025
Shares of senior living provider The Pennant Group (NASDAQ:PNTG)
fell 7.8% in the morning session after the company reported mixed third-quarter results, where underlying weaknesses overshadowed headline beats on revenue and adjusted earnings. Pennant's revenue grew 26.8% from the previous year to $229 million, and its adjusted earnings per share came in at $0.30, both ahead of analyst estimates. However, investors focused on less favorable details in the report. The company's adjusted EBITDA, a key measure of profitability, missed analyst expectations. Furthermore, Pennant's operating margin fell to 4.5% from 6% in the same quarter of the prior year. While the company did raise its full-year revenue outlook, the drop in these key profitability metrics appeared to weigh more heavily on investor sentiment, overshadowing the positive top-line results.
Via StockStory · November 6, 2025
EAGLE, Idaho, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2025 Stephens Annual Investment Conference on November 19, 2025.
By Pennant Group, Inc. · Via GlobeNewswire · November 6, 2025
Senior living provider The Pennant Group (NASDAQ:PNTG) announced better-than-expected revenue in Q3 CY2025, with sales up 26.8% year on year to $229 million. The company’s full-year revenue guidance of $930 million at the midpoint came in 3.5% above analysts’ estimates. Its non-GAAP profit of $0.30 per share was 4.6% above analysts’ consensus estimates.
Via StockStory · November 5, 2025
EAGLE, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that the Company has added a term loan to its credit facility, increasing the facility by $100 million to an aggregate of $350 million. The borrowings are supported by Pennant’s existing lending consortium led by Truist Securities. The interest rate and maturity date of the incremental loan match those of the existing facility.
By Pennant Group, Inc. · Via GlobeNewswire · November 5, 2025
Conference Call and Webcast scheduled for tomorrow, November 6, 2025 at 10:00 am MT
By Pennant Group, Inc. · Via GlobeNewswire · November 5, 2025
EAGLE, Idaho, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces two significant acquisitions that strengthen its presences in key markets.
By Pennant Group, Inc. · Via GlobeNewswire · November 4, 2025
Senior living provider The Pennant Group (NASDAQ:PNTG)
will be announcing earnings results this Wednesday after market hours. Here’s what you need to know.
Via StockStory · November 3, 2025
EAGLE, Idaho, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its third quarter 2025 financial results on Wednesday, November 5, 2025.
By Pennant Group, Inc. · Via GlobeNewswire · October 24, 2025
Shares of senior living provider The Pennant Group (NASDAQ:PNTG)
jumped 5.2% in the afternoon session after the investment firm Jefferies initiated coverage on the company with a 'Buy' rating and a $30 price target.
Via StockStory · October 24, 2025
Via Benzinga · October 24, 2025
Growth is oxygen.
But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
Via StockStory · October 22, 2025
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Via StockStory · October 16, 2025
Let’s dig into the relative performance of The Pennant Group (NASDAQ:PNTG) and its peers as we unravel the now-completed Q2 senior health, home health & hospice earnings season.
Via StockStory · October 12, 2025
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
Via StockStory · October 10, 2025